Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

about

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

Item

http://www.wikidata.org/entity/Q46178714

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

@en

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

@nl

type

Item

label

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

@en

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

@nl

prefLabel

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

@en

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

@nl

P1476

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

@en

P2093

E Hampton Sessions

http://www.w3.org/2001/XMLSchema#string

Elena B Pasquale

http://www.w3.org/2001/XMLSchema#string

Gregory P Roth

http://www.w3.org/2001/XMLSchema#string

Robert Williamson

http://www.w3.org/2001/XMLSchema#string

Romain Stalder

http://www.w3.org/2001/XMLSchema#string

Stefan J Riedl

http://www.w3.org/2001/XMLSchema#string

P2860

Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove

The selectivity of protein kinase inhibitors: a further update

Targeting the Eph System with Peptides and Peptide Conjugates

Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet

Bivalent inhibitors of protein kinases

Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control

Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK

Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors

Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development

Discovery of 1-(1H-Pyrazolo[4,3-c]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of Cancers

P304

726-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.7B00127

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Peter D. Mace

Yann Wallez

Bernhard C Lechtenberg

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28740606

http://www.w3.org/2001/XMLSchema#string

P932

5512124

http://www.w3.org/2001/XMLSchema#string